Squarepoint
TMDX icon

Squarepoint’s Transmedics TMDX Stock Holding History

Squarepoint’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,700
Closed -$640K – 4894
2025
Q3 		$640K Buy
5,700
+1,000
+21% +$117K ﹤0.01% 3036
2025
Q2 		$630K Sell
4,700
-2,300
-33% -$253K ﹤0.01% 3074
2025
Q1 		$471K Buy
+7,000
New +$481K ﹤0.01% 3361

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint's TMDX Position: Q1 2026 in Review

Squarepoint reduced its Transmedics (TMDX) stake by 93% in Q1 2026, selling an estimated $13.5M and leaving 7,274 shares worth $723K. The position accounts for ﹤0.01% of the portfolio, ranked #3041.

Squarepoint first reported a position in TMDX in Q2 2019 and has held it in 23 quarters since. The position peaked at $35.6M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Squarepoint held 7,274 shares of Transmedics worth $723K as of Q1 2026.
  • Squarepoint sold 103,222 Transmedics shares in Q1 2026, an estimated $13.5M.
  • Transmedics made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3041 holding.
  • Squarepoint first reported a position in Transmedics in Q2 2019 and has held it in 23 quarters since.
  • Squarepoint's Transmedics position peaked at $35.6M in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.